|
President of the Novartis Institutes for BioMedical Research Member of the Executive Committee of Novartis
Mark C. Fishman, M.D., is President of the Novartis Institutes for BioMedical Research (NIBR) and a member of the Executive Committee of Novartis, a position he assumed in May 2002. From the NIBR headquarters in Cambridge, Massachusetts, he leads the worldwide discovery research activities of Novartis in Europe, the US, Japan and China. Prior to joining Novartis, Dr. Fishman was Professor of Medicine at Harvard Medical School and Chief of Cardiology at the Massachusetts General Hospital (MGH). He was also the founding Director of the Cardiovascular Research Center of the MGH. He continues to serve as a Consultant in Medicine at the MGH. As a clinician and scientist, Dr. Fishman is pre-eminent in the fields of genetic and molecular cardiology, with a principal focus on embryonic heart development. He is best known for his studies in developmental genetics, in particular his role in introducing the zebrafish as a model for gene discovery.
Dr. Fishman serves on several editorial boards and has worked with national policy and scientific committees, including those of the National Institutes of Health and the Wellcome Trust. He has been honored with many awards and distinguished lectureships, is a Fellow of the American Academy of Arts and Sciences, and a member of the Institute of Medicine of the National Academies, US. | 